rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michele Ilene Korfin

Director

Company insider

Files Form 4 as: Director, Organogenesis Holdings; COO/Chief Commercial Officer, Gamida Cell; Chief Operating Officer, Tyme Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
14
Buys
1
Sells
0
Bought
$5,150
Sold
$0
Companies
3
Companies where not an officer
1
First trade
7 May 2019
Last trade
18 Feb 2026
Last filed
20 Feb 2026

Companies traded

Where they are an officer
Gamida CellOfficer · last 31 Jan 20240 buys · 0 sells
Tyme TechnologiesOfficer · last 7 May 20201 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ORGO Organogenesis HoldingsDirector · Biotechnology · last 18 Feb 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
18 Feb 2026filed 20 Feb 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—48,828 at $0.00filing
18 Feb 2026filed 20 Feb 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—48,828 at $0.00filing
19 Feb 2025filed 21 Feb 2025ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—49,575 at $0.00filing
21 Feb 2024filed 23 Feb 2024ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—51,020 at $0.00filing
31 Jan 2024filed 2 Feb 2024Gamida CellSEC FORM 4 Code A—480,319 at $0.00filing
22 Feb 2023filed 24 Feb 2023ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—65,737 at $0.00filing
8 Feb 2023filed 10 Feb 2023Gamida Celloption or derivativeSEC FORM 4 Code A—186,150 at $0.00filing
8 Feb 2023filed 10 Feb 2023Gamida CellSEC FORM 4 Code A—92,990 at $0.00filing
3 May 2022filed 5 May 2022ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—23,913 at $0.00filing
28 Jan 2022filed 1 Feb 2022Gamida Celloption or derivativeSEC FORM 4 Code A—125,000 at $0.00filing
28 Jan 2022filed 1 Feb 2022Gamida CellSEC FORM 4 Code A—63,800 at $0.00filing
7 May 2020filed 18 May 2020Tyme Technologiesoption or derivativeSEC FORM 4 Code A—360,000 at $0.00filing
14 Jun 2019filed 17 Jun 2019Tyme TechnologiesSEC FORM 4 Bought$5,1505,000 at $1.03filing
7 May 2019filed 9 May 2019Tyme Technologiesoption or derivativeSEC FORM 4 Code A—375,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.